Monte Rosa Therapeutics I... (GLUE)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
5.80
0.24 (4.32%)
At close: Jan 15, 2025, 12:01 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -2.15 | -3.44 | -13.21 | -25.84 | -116.25 |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.62 | 1.32 | 2.73 | -19.13 | -76.72 |
P/FCF Ratio | -4.62 | -3.41 | -13.75 | -35.25 | -123.31 |
P/OCF Ratio | -6.63 | -3.89 | -16.01 | -40.43 | -150.98 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.26 | 0.17 | n/a | -1.39 | -0.06 |
Quick Ratio | 5.07 | 10.75 | 20.96 | 1.49 | 2.27 |
Current Ratio | 5.07 | 10.79 | 20.96 | 1.49 | 2.27 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -29.86 | n/a | n/a | -7.99K |
Return on Equity (ROE) | -0.76 | -0.39 | -0.21 | 0.74 | 0.66 |
Return on Assets (ROA) | -0.45 | -0.31 | -0.2 | -0.73 | -0.72 |
Return on Capital (ROIC) | -0.56 | -0.35 | -0.21 | -1.39 | -1.18 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |